Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$49.62 - $58.13 $893 - $1,046
-18 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$62.61 - $71.29 $2,880 - $3,279
-46 Reduced 71.88%
18 $1,000
Q2 2020

Aug 13, 2020

SELL
$39.55 - $54.65 $672 - $929
-17 Reduced 20.99%
64 $3,000
Q1 2020

May 15, 2020

BUY
$34.75 - $45.85 $2,606 - $3,438
75 Added 1250.0%
81 $3,000
Q4 2019

Jan 28, 2020

BUY
$36.66 - $41.78 $219 - $250
6 New
6 $0
Q1 2019

Aug 16, 2019

SELL
$35.77 - $40.57 $7,905 - $8,965
-221 Closed
0 $0
Q4 2018

Apr 16, 2019

BUY
$31.89 - $38.44 $7,047 - $8,495
221 New
221 $8,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.